Response by Yamashita et al to Letter Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”
Y
Yugo Yamashita
(Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan (Y.Y.).)
T
Takeshi Morimoto
T
Takeshi Kimura
Article Details
Journal
Circulation
Volume / Issue
Vol. 152, Issue 10
Published
September 09, 2025
ISSN
0009-7322
Publisher
Lippincott Williams & Wilkins
Authors (3)
Y
Yugo Yamashita
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan (Y.Y.).
T
Takeshi Morimoto
T
Takeshi Kimura
Related Articles from this Journal
Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations
Johanna Mueller-Leisse, Henrike Aenne Katrin Hillmann et al.
Aug 2026
10.1161/circulationaha.126.080556
Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Albert J. Rogers, Sabyasachi Bandyopadhyay et al.
Aug 2026
10.1161/circulationaha.126.080755
Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>
Jennifer E. Ho, Ryan J. Tedford
Aug 2026
10.1161/circulationaha.126.080205
ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction
Yu Liu, Yijin Chen et al.
Aug 2026
10.1161/circulationaha.125.078593
Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Dong Li, Shuang Zhang et al.
Aug 2026
10.1161/circulationaha.126.079996